In Vitro Antibody Discovery Intern, Master's and PhD Students jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 1 day ago

In Vitro Antibody Discovery Intern, Master's and PhD Students

AstraZeneca is seeking Master’s and PhD level students for a 12-week internship role in Gaithersburg, MD. The role involves performing wet lab experiments, analyzing and organizing experimental results, and accurate data capture.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Perform wet lab experiments (phage and yeast culture, ELISA, flow cytometry, etc.)
Analyze and organize experimental results using Prism, Microsoft Excel, PowerPoint, Word, etc. for oral and poster presentations
Accurate and precise data capture using Signals ELN and Genedata Biologics

Qualification

Wet lab skillsPrismCell cultureELISAFlow cytometryMicrosoft OfficeAutomation familiarityHigh-throughput experiments

Required

Master's and PhD level students majoring in Biochemistry, Biomedical Engineering, Biotechnology, Molecular Biology, Cell Biology or a related discipline. Candidates must have an expected graduation date after August 2026
Basic wet lab skills such as pipetting and reagent preparation are required
Proficiency in Prism and Microsoft Office tools, such as Outlook, Excel, PowerPoint, and Word are required
Ability to report onsite to Gaithersburg, MD 3-5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing OPT support

Preferred

Previous hands-on experience of performing cell culture, ELISA, BLI, and flow cytometry are a plus
Familiarity with automation and high-throughput experiment set up is highly preferred

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase